Eplerenone for preventing atrial fibrillation return
Part of Heart & circulation clinical trials.
This trial is testing whether a medication called eplerenone can help prevent atrial fibrillation (AF) from coming back in people who have structural heart disease and have already had their heart rhythm restored to normal. It may be a good option if you are looking for a way to keep your heart in a normal rhythm.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have non-valvular atrial fibrillation (AF) that has been converted back to a normal heart rhythm (sinus rhythm) either by medication, an electrical shock, or on its own.
- You do not have rheumatic heart disease.
- You do not have thyroid problems.
- You do not have Wolff-Parkinson-White (WPW) syndrome.
- You do not have kidney problems or high potassium levels.
- You have not recently had a heart attack or unstable angina, and you are not pregnant.
- Your heart's pumping function (ejection fraction) is 40% or higher.
- You are not currently taking eplerenone.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether ezetimibe, a cholesterol-lowering medication, can help prevent atrial fibrillation (an irregular heartbeat) from coming back after a procedure called catheter ablation. If you are scheduled for your first ablation for persistent atrial fibrillation, this trial may help you maintain a normal heart rhythm.
This study tests a stepwise treatment plan for people with persistent atrial fibrillation (a long-lasting irregular heartbeat) who also have an enlarged left atrium. It aims to see if a medication called amiodarone plus a cardioversion procedure can help restore normal rhythm.
This trial tests if enavogliflozin, a diabetes drug, can help prevent atrial fibrillation (an irregular heartbeat) from coming back after a catheter ablation procedure in people with heart failure. If you've recently had or are planning this procedure, this study may offer a new way to keep your heart rhythm steady.
This study tests if a specific exercise program can reduce how often atrial fibrillation (a type of irregular heartbeat) happens. If you have non-permanent atrial fibrillation and are willing to follow an exercise plan, this trial might help you manage your condition.
This study tests a new drug called BAY 3670549 to see if it can help convert atrial fibrillation (an irregular heartbeat) back to normal rhythm. You'll receive the study drug or a placebo along with a procedure to restore your heart's normal rhythm, and researchers will monitor how well it works and how safe it is.
This study tests whether eplerenone (a pill that helps control heart rhythm) can prevent atrial fibrillation from coming back in people with structural heart disease. You may qualify if your AF is the coming-and-going type and you've already been returned to a normal rhythm.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.